Mosaic Debt-Funds Dividend as UBS Cuts to $19
UBS cut Mosaic to a $19 price target, the most bearish analyst call on the Street. The deeper problem: the company finances a $0.22 quarterly dividend from negative $746M annual free cash flow, backed
UBS Cuts Mosaic to $19 as Dividend Tests Negative FCF
NEW YORK, October 27 —
UBS's cut of The Mosaic Company (MOS) to a $19 price target leaves Wall Street's most bearish analyst call just $0.57 above where the stock trades, but the structural problem predates this note: Mosaic declared a $0.22 quarterly dividend that its own free cash flow cannot come close to funding.
- Free cash flow is negative $746M annually; $290M in cash sits against $6.08B in total debt.
- Three consecutive earnings misses include a 77.1% shortfall in Q2 2026; trailing EPS is negative $2.01.
- SVP Precourt sold 23,000 shares at $22.12 in August; the stock now trades at $18.43.
The Debt-Funded Payout
Mosaic manufactures phosphate and potash crop nutrients, specifically diammonium phosphate (DAP), monoammonium phosphate (MAP), the value-added MicroEssentials line, K-Mag, and the Biofos and Nexfos feed phosphate brands, selling through distributors and exporting to Brazil, China, India, and Australia. Trailing revenue of $12.25 billion has declined 6% year-over-year, and gross margin stands at just 11.2%. The company generates $444 million in operating cash flow but spends enough on capital expenditures to produce negative $746 million in free cash flow annually. With $290 million in cash against $6.08 billion in debt, each quarterly dividend check is effectively debt-financed.
Three Misses and an Insider Exit
After a Q4 2025 beat of 9.5% above consensus, Mosaic posted three consecutive misses: Q1 2026 at 53.4% below estimates, Q2 2026 at 77.1% below, and Q3 2026 at 5.8% below, leaving trailing EPS at negative $2.01. Short interest stands at 12.5% of the float. SVP and Chief Administrative Officer Walter F. Precourt III sold 23,000 shares at $22.12 in August 2026; the stock now trades at $18.43, making his exit well-timed. Net insider activity over the 90-day window totals $508,760 in open-market sales against zero in open-market purchases.
| Ticker | Mkt cap | Fwd P/E | 52-wk |
|---|---|---|---|
| MOS | $5.9B | 12.1x | -39.7% |
| CF | $18.2B | 10.6x | +40.3% |
| NTR | $33.0B | 13.7x | +19.7% |
| IPI | $422M | 22.7x | +15.1% |
| BG | $19.5B | 9.1x | +6.1% |
| FCX | $94.9B | 15.2x | +58.3% |
The Bear Case's One Exit Ramp
UBS's $19 target sits $7 below a Street consensus near $26, the most bearish analyst call in the coverage. At 12.1x forward earnings, the multiple offers cold comfort given the earnings trajectory. The Q4 2026 report is the first real checkpoint: a free cash flow figure trending toward positive would challenge the bear case, while another deeply negative reading puts the quarterly payout in direct conflict with a leveraged balance sheet. Stress-test the assumptions with the DCF calculator, or run the free The Mosaic Company deep-dive → to track whether fundamentals are inflecting.
Basis Report is independent research for informational purposes. It is not investment advice and not a recommendation to buy or sell any security.
Frequently Asked Questions
Can Mosaic afford its dividend?
Mosaic declared a $0.22 quarterly dividend despite negative $746 million in annual free cash flow. With only $290 million in cash against $6.08 billion in total debt, each dividend payment is effectively debt-financed.
Why did UBS cut Mosaic?
UBS cut its Mosaic price target to $19, the most bearish analyst call on Wall Street. The company has posted three consecutive earnings misses with trailing EPS of negative $2.01 per share, and its free cash flow cannot support the dividend.
What is Mosaic's business?
Mosaic manufactures phosphate and potash crop nutrients including diammonium phosphate (DAP), monoammonium phosphate (MAP), the MicroEssentials line, K-Mag, and Biofos and Nexfos feed phosphate brands. The company sells through distributors and exports to Brazil, China, India, and Australia.
How severe were recent earnings misses?
Mosaic posted a Q4 2025 beat of 9.5% above consensus but then three consecutive misses: Q1 2026 at 53.4% below, Q2 2026 at 77.1% below, and Q3 2026 at 5.8% below. Trailing EPS stands at negative $2.01.
Did insiders sell ahead of the decline?
SVP and Chief Administrative Officer Walter F. Precourt III sold 23,000 shares at $22.12 in August 2026. The stock now trades at $18.43. Net insider activity over 90 days totals $508,760 in sales against zero in purchases.
UBS cut its Mosaic price target to $19 from $23 on October 27, leaving the target just above the stock's $18.43 price — the most pessimistic call on a Street whose consensus still sits near $26. The reduction arrives days after Mosaic declared a $0.22 quarterly dividend that its negative $746 million in free cash flow cannot self-fund.